首页> 外文期刊>Circulation research: a journal of the American Heart Association >Intracellular Ca2+ silences L-type Ca2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers.
【24h】

Intracellular Ca2+ silences L-type Ca2+ channels in mesenteric veins: mechanism of venous smooth muscle resistance to calcium channel blockers.

机译:细胞内Ca2 +使肠系膜静脉中的L型Ca2 +通道沉默:静脉平滑肌对钙通道阻滞剂抵抗的机制。

获取原文
获取原文并翻译 | 示例
           

摘要

RATIONALE: Calcium channel blockers (CCBs) exert their antihypertensive effect by reducing cardiac afterload but not preload, suggesting that Ca(2+) influx through L-type Ca(2+) channels (LTCC) mediates arterial but not venous tone. Objective: The object of this study was to resolve the mechanism of venous resistance to CCBs. METHODS AND RESULTS: We compared the sensitivity of depolarization (KCl)-induced constriction of rat small mesenteric arteries (MAs) and veins (MVs) to the dilator effect of CCBs. Initial findings confirmed that nifedipine progressively dilated depolarization-induced constrictions in MAs but not MVs. However, Western blots showed a similar expression of the alpha(1C) pore-forming subunit of the LTCC in both vessels. Patch-clamp studies revealed a similar density of whole-cell Ca(2+) channel current between single smooth muscle cells (SMCs) of MAs and MVs. Based on these findings, we hypothesized that LTCCs are expressed but "silenced" by intracellular Ca(2+) in venous SMCs. After depletion of intracellular Ca(2+) stores by the SERCA pump inhibitor thapsigargin, depolarization-induced constrictions in MVs were blocked 80% by nifedipine suggesting restoration of Ca(2+) influx through LTCCs. Similarly, KCl-induced constrictions were sensitive to block by nifedipine after depletion of intracellular Ca(2+) stores by caffeine, ryanodine, or 2-aminoethoxydiphenyl borate. Cell-attached patch recordings of unitary LTCC currents confirmed rare channel openings during depolarization of venous compared to arterial SMCs, but chelating intracellular Ca(2+) significantly increased the open-state probability of venous LTCCs. CONCLUSIONS: We report that intracellular Ca(2+) inactivates LTCCs in venous SMCs to confer venous resistance to CCB-induced dilation, a fundamental drug property that was previously unexplained.
机译:理由:钙通道阻滞剂(CCBs)通过降低心脏后负荷而不是预负荷来发挥其降压作用,表明Ca(2+)通过L型Ca(2+)通道(LTCC)流入介导了动脉但没有静脉音。目的:本研究的目的是解决静脉对CCBs耐药的机制。方法和结果:我们比较了去极化(KCl)诱导的大鼠小肠系膜动脉(MAs)和静脉(MVs)收缩对CCB扩张作用的敏感性。初步发现证实,硝苯地平会逐渐扩张去极化诱导的MAs收缩,而不是MVs。但是,蛋白质印迹显示在两个血管中LTCC的alpha(1C)孔形成亚基的相似表达。膜片钳研究显示MAs和MVs的单个平滑肌细胞(SMC)之间的全细胞Ca(2+)通道电流的密度相似。基于这些发现,我们假设LTCCs被表达但被静脉SMC中的细胞内Ca(2+)沉默。 SERCA泵抑制剂thapsigargin耗尽细胞内Ca(2+)存储后,硝苯地平阻止去极化诱导的MV收缩80%,这表明通过LTCCs恢复了Ca(2+)流入。同样,KCl诱导的收缩敏感后被咖啡因,ryanodine或2-氨基乙氧基二苯硼酸盐耗尽细胞内Ca(2+)存储后被硝苯地平阻滞。单元LTCC电流的细胞附着补丁记录证实,与动脉SMC相比,静脉去极化过程中罕见的通道开放,但螯合细胞内Ca(2+)显着增加了静脉LTCC的开放状态可能性。结论:我们报告细胞内Ca(2+)灭活静脉SMCs中的LTCC,以赋予静脉对CCB诱导的扩张的抵抗力,这是以前无法解释的基本药物特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号